Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To demonstrate that QVA149 (110/50 μg o.d.) is superior to NVA237 (50 μg o.d.) with regard to the rate of moderate to severe COPD exacerbations during 52 weeks of treatment.
Inclusion criteria
- Chronic Obstructive Pulmonary Disease (COPD)